Allient (NASDAQ:ALNT - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "hold" rating in a research report issued to clients and investors on Saturday.
ALNT has been the subject of several other research reports. JPMorgan Chase & Co. reduced their price target on shares of Allient from $70.00 to $65.00 and set a "neutral" rating for the company in a research report on Friday. Lake Street Capital initiated coverage on shares of Allient in a research report on Wednesday, February 18th. They set a "buy" rating and a $79.00 price target for the company. Craig Hallum reaffirmed a "buy" rating and set a $75.00 price target on shares of Allient in a research report on Monday, March 9th. Roth Mkm reaffirmed a "buy" rating and set a $70.00 price target on shares of Allient in a research report on Friday. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Allient in a research report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $72.25.
View Our Latest Research Report on Allient
Allient Price Performance
Shares of NASDAQ:ALNT opened at $66.69 on Friday. Allient has a fifty-two week low of $27.00 and a fifty-two week high of $80.39. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of 46.64 and a beta of 1.65. The company has a debt-to-equity ratio of 0.58, a quick ratio of 2.08 and a current ratio of 3.73. The business has a 50-day simple moving average of $66.64 and a two-hundred day simple moving average of $60.72.
Allient (NASDAQ:ALNT - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.50 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.05). Allient had a net margin of 4.25% and a return on equity of 12.47%. The business had revenue of $138.92 million for the quarter, compared to analysts' expectations of $138.42 million. On average, analysts expect that Allient will post 2.58 earnings per share for the current year.
Institutional Investors Weigh In On Allient
A number of institutional investors have recently added to or reduced their stakes in ALNT. Royal Bank of Canada grew its holdings in Allient by 19.8% during the 1st quarter. Royal Bank of Canada now owns 111,570 shares of the company's stock valued at $2,453,000 after buying an additional 18,416 shares in the last quarter. AQR Capital Management LLC grew its holdings in Allient by 8.0% during the 1st quarter. AQR Capital Management LLC now owns 53,661 shares of the company's stock valued at $1,179,000 after buying an additional 3,979 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Allient by 4.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,736 shares of the company's stock valued at $192,000 after buying an additional 390 shares in the last quarter. Empowered Funds LLC grew its holdings in Allient by 8.1% during the 1st quarter. Empowered Funds LLC now owns 46,044 shares of the company's stock valued at $1,012,000 after buying an additional 3,458 shares in the last quarter. Finally, Jane Street Group LLC grew its holdings in Allient by 9.9% during the 1st quarter. Jane Street Group LLC now owns 18,379 shares of the company's stock valued at $404,000 after buying an additional 1,663 shares in the last quarter. 61.57% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting Allient
Here are the key news stories impacting Allient this week:
- Positive Sentiment: Allient said Q1 2026 results featured revenue growth, margin expansion, and strong bookings, which supports the case for improving operating momentum. Allient Reports Revenue Growth, Margin Expansion and Strong Bookings for First Quarter 2026
- Positive Sentiment: The company also increased its quarterly dividend to $0.04 per share from $0.03, a 33.3% boost, signaling confidence in cash flow and returning more capital to shareholders.
- Positive Sentiment: Allient remains a focus in broader technology-sector coverage and continues to attract attention from institutional holders, including FMR LLC’s 12.1% stake.
- Neutral Sentiment: The company plans to attend UAV Technology USA 2026, which may help investor outreach but is not a major immediate financial catalyst. Allient Inc. to Attend UAV Technology USA 2026
- Neutral Sentiment: JPMorgan lowered its price target on Allient to $65 from $70 and kept a neutral rating, which suggests limited upside from current levels and may temper enthusiasm. Benzinga report on JPMorgan price target cut
- Negative Sentiment: Despite revenue meeting expectations, the Q1 earnings release was followed by a sharp stock drop as investors focused on the miss in EPS versus estimates and the market’s cautious reaction to the quarter. Allient’s NASDAQ: ALNT Q1 CY2026 Earnings Results: Revenue In Line With Expectations But Stock Drops 11.9%
About Allient
(
Get Free Report)
Allient Inc, together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allient wasn't on the list.
While Allient currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.